Date(s) And Time(s):
Nov 1 2011 7:00AM - Nov 2 2011 3:00PM
100 Kent Street
Ottawa, ON K1P5R7
CALL FOR ABSTRACTS
ALL ABSTRACTS ARE DUE BY MAY 16, 2011
ABSTRACT AUTHORS NOTIFIED BY JUNE 10, 2011
Please submit all poster abstracts using the online form at:
All abstracts must be received by May 16, 2011.
Abstracts will be reviewed and authors will be notified of results by June 10, 2011.
The biopharmaceutical community continues to experience paradigm
shifts in drug development. Further global changes occur with respect to
drug development and regulatory oversight and traditional and non-traditional
partnerships in healthcare. Several factors influencing these changes
include: new scientific approaches; biomarkers and individualized medicines;
health care reform; technological advances; and the interplay
between safety pharmacovigilence and effectiveness research. In order to
remain competitive, Canada will need to foster innovation in these areas to
facilitate market access to medicines.
The rapid pace of change will create new opportunities and challenges to
our current ways of thinking and operating. This program will highlight
information on changes occurring to drug development models, regulatory
oversight frameworks and new emerging opportunities and challenges
with traditional and non-traditional partnerships in healthcare.
Monday, October 31, 2011 — Preregistration required.
Contact Joanne Wallace, Program Manager, Phone +1.215.442.6180
Fax +1.215.293.5931, email Joanne Wallace@diahome.org
Attendees may visit the exhibits during the event and receptions.
Contact Jeff Korn, Exhibits Associate, Phone +1.215.442.6184
Fax +1.215.293.5924, email Jeff.Korn@diahome.org